论文部分内容阅读
目的:分析鼻内窥镜下鼻腔泪囊造口术在治疗慢性泪囊炎疾病中发挥的作用,阐述其临床应用的价值与意义。方法:特选取我院诊治的慢性泪囊炎患者59例,随机平均分为两组,对照组29例,观察组30例,对照组患者实施药物治疗,观察组患者实施鼻内窥镜下鼻腔泪囊造口术治疗,以患者的治疗总有效率、并发症发生率和疾病的复发率等为观察指标,比较两组患者的治疗情况。结果:观察组治疗总有效率明显高于对照组,疾病的复发率显著低于对照组,但是并发症的发生率远不及对照组低,两组间就上述差异进行比较,P<0.05有统计学意义;总体来说观察组效果更为显著。结论:与药物治疗相比,手术治疗慢性泪囊炎疾病效果更为显著,治疗更为彻底,而鼻内窥镜下鼻腔泪囊造口术可作为临床治疗该病的首选手段,具有操作相对简便、安全性高等优势,具有较高的临床应用价值。
OBJECTIVE: To analyze the role of nasal lacrimal sac stoma under nasal endoscopy in the treatment of chronic dacryocystitis and to elucidate the value and significance of its clinical application. Methods: 59 cases of chronic dacryocystitis selected from our hospital were randomly divided into two groups randomly. The control group (n = 29), the observation group (n = 30) and the control group (n = 30) received drug treatment. The observation group underwent nasal endoscopic nasal cavity Dacryocystorhinostomy treatment, with the total effective rate of treatment, the incidence of complications and the recurrence rate of the disease as the indicators to compare the treatment of patients in both groups. Results: The total effective rate of the observation group was significantly higher than that of the control group, the recurrence rate of the disease was significantly lower than that of the control group, but the complication rate was far lower than that of the control group. The differences were compared between the two groups Significance of the study; Overall observation group effect is more significant. CONCLUSIONS: Surgical treatment of chronic dacryocystitis is more effective than drug treatment in treatment of more complete diseases. Nasal lacrimal sacostomy under nasal endoscopy can be used as the first choice for clinical treatment of this disease. Simple, high safety advantages, with high clinical value.